MedPath

A clinical trial of Unani medicine in the disease of Melasma.

Phase 2
Conditions
Health Condition 1: L811- Chloasma
Registration Number
CTRI/2024/06/068821
Lead Sponsor
DEPARTMENT OF AMRAZ E JILD WA ZOHRAWIYA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age- 18 years and above.

Both male and female patients.

All skin types (Fitzpatrick I to VI).

Patients who signed the written consent form.

Epidermal and mixed pattern of melasma.

Exclusion Criteria

Patients below 18 years.

Patient with systemic disease eg: DM, Malignancy, Thyroid dysfunction, CKD, and TB (as per history and clinical examination).

History of hypersensitivity reaction to drugs.

Patients who were not willing to sign the consent form or remain absent during the study.

Pregnant and Lactating mothers.

Women who are on OCPs (progesterone).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath